E
Nyxoah SA NYXH
$2.95 $0.020.68% NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
Corporate Info
Phone Number
32 1 045 90 75
Address
Rue Edouard Belin 12
Mont-Saint-Guibert, 1435
Country
Belgium
Year Founded
2009
Details
Sector
Health Care
Industry
Health Care Equipment and Services
Employees
Business Description
Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat obstructive sleep apnea. Its lead solution is the Genio system, a hypoglossal neurostimulations therapy for obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.